Pharmacogenetic testing can inform medication choice and adverse effect risk, while questions remain about implementation, data storage, and access in routine care.

Even though a large proportion of cancer patients carry genetic mutations that make them more susceptible to cancer, only a small percentage of them — and their family members — undergo potentially ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Current genetic tests often miss crucial large-scale DNA structural changes, like ...

There are different forms of embryo testing. Some tests screen for broader chromosomal abnormalities and cannot guarantee an ...

The meaning of a result depends on the particular variant, the dog’s breed, and whether other genes or environmental factors ...

Genetic testing can help doctors diagnose some neurological disorders, such as Huntington’s disease. It can also provide insights into a person’s risk of future health conditions. Genetic testing ...

Genetic testing for ATTR can detect transthyretin mutations and offer crucial information about risk, monitoring, and treatment, if needed. Transthyretin amyloidosis (ATTR) is a genetic condition that ...

A new consensus statement recommended genetic testing for all categories of kidney diseases whenever a genetic cause is suspected and offered guidance on who to test, which tests are the most useful, ...

Genetic testing for chronic myeloid leukemia (CML) can tell doctors if someone has leukemia, what type they may have, and whether treatment is working. The tests look for atypical changes in certain ...

A genetic marker already used to flag the risk of a life-threatening reaction to the antibiotic vancomycin also identifies ...

Breaking down the results.